|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300076798 |
|
最近更新日期: Date of Last Refreshed on: |
2023-10-18 16:51:59 |
|
注册时间: Date of Registration: |
2023-10-18 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于丰富环境理论的患者ICU后综合征预防方案临床应用研究 |
|
Public title: |
Clinical application of post-ICU syndrome prevention program in patients based on enriched environment theory |
|
注册题目简写: |
预防方案临床应用研究 |
|
English Acronym: |
Study on clinical application of prevention program |
|
研究课题的正式科学名称: |
基于丰富环境理论的患者ICU后综合征早期预防方案的构建及初步应用 |
|
Scientific title: |
Construction and preliminary application of early post-ICU syndrome prevention program in patients based on enriched environment theory |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
倪萍 |
研究负责人: |
胡少华 |
|
Applicant: |
Ni Ping |
Study leader: |
Hu Shaohua |
|
申请注册联系人电话: Applicant telephone: |
+86 199 6530 5530 |
研究负责人电话:
Study leader's |
+86 139 0969 6207 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
ahmunp@163.com |
研究负责人电子邮件: Study leader's E-mail: |
paper2390@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
安徽省合肥市蜀山区梅山路81号安徽医科大学 |
研究负责人通讯地址: |
安徽省合肥市蜀山区梅山路81号安徽医科大学 |
|
Applicant address: |
No.81 Meishan Road, Shushan District, Hefei City, Anhui Province, Anhui Medical University |
Study leader's address: |
No.81 Meishan Road, Shushan District, Hefei City, Anhui Province, Anhui Medical University |
|
申请注册联系人邮政编码: Applicant postcode: |
230032 |
研究负责人邮政编码: Study leader's postcode: |
230032 |
|
申请人所在单位: |
安徽医科大学护理学院 |
||
|
Applicant's institution: |
School of Nursing, Anhui Medical University |
||
|
研究负责人所在单位: |
安徽医科大学护理学院 |
||
|
Affiliation of the Leader: |
School of Nursing, Anhui Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
84220051 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
安徽医科大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Ethics Committee, Anhui Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-01-01 00:00:00 | ||
|
伦理委员会联系人: |
王华 |
||
|
Contact Name of the ethic committee: |
Wang Hua |
||
|
伦理委员会联系地址: |
安徽省合肥市蜀山区梅山路81号安徽医科大学 |
||
|
Contact Address of the ethic committee: |
No.81 Meishan Road, Shushan District, Hefei City, Anhui Province, Anhui Medical University |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 551 6516 1057 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
安徽医科大学护理学院 |
||||||||||||||||||||||
|
Primary sponsor: |
School of Nursing, Anhui Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
安徽省合肥市蜀山区梅山路81号安徽医科大学 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.81 Meishan Road, Shushan District, Hefei City, Anhui Province, Anhui Medical University |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
安徽省临床重点专科建设项目(皖卫传[2019]91号) |
||||||||||||||||||||||
|
Source(s) of funding: |
Clinical Key Specialty Construction Project of Anhui Province (Wanwei Transmission [2019] No. 91) |
||||||||||||||||||||||
|
研究疾病: |
重症监护室后综合征 |
||||||||||||||||||||||
|
Target disease: |
post-intensive care syndrome |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究拟基于丰富环境理论制定ICU患者早期干预方案并初步应用,探讨丰富环境对预防ICU后综合征的效果,旨在帮助医护人员了解丰富环境对预防患者ICU后综合征的效果,为后续指导ICU患者的早期康复锻炼提供实践依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on the theory of enriched environment, this study intends to develop early intervention programs for ICU patients and preliminarily apply them and explore the effect of enriched environment on the prevention of post-ICU syndrome, aiming to help medical staff understand the effect of enriched environment on the prevention of post-ICU syndrome, and provide practical basis for the follow-up guidance of early rehabilitation exercises for ICU patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
无 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
Non |
||||||||||||||||||||||
|
纳入标准: |
①入住ICU且意识清楚的患者; ②年龄≥18 岁; ③患者入住ICU前2周的Barthel指数评分≥75分; ④首次入住ICU; ⑤自愿参加并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
① Patients admitted to ICU with clear consciousness. ② Age ≥18 years old. ③ The Barthel index score of the patient was ≥75 points 2 weeks before ICU admission. ④ First admission to ICU. ⑤ Participate voluntarily and sign informed consent. |
||||||||||||||||||||||
|
排除标准: |
①ICU 住院时间<7 天; ②既往存在肢体、认知、精神、视力、听力功能障碍者; ③不能配合干预及量表测试者; ④可能影响研究结果的疾病,如重度脑外伤、急性神经系统受损事件(如脑血管意外、蛛网膜下腔出血等); ⑤研究中途退出者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
①Length of ICU stay < 7 days. ② Previous physical, cognitive, mental, visual, hearing impairment. ③ Can not cooperate with the intervention and scale test. ④ Diseases that may affect the results of the study, such as severe brain trauma, acute nervous system damage events (such as cerebrovascular accidents, subarachnoid hemorrhage, etc.). (5) People who quit during the study. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-10-19 00:00:00至 To 2024-08-15 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-10-19 00:00:00 至 To 2024-08-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究者通过随机数字网站(http://tools.medsci.cn/rand)产生80个随机序列,将该序列从小到大排序,前40个为干预组,后40个为对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Researchers produced by random number website (http://tools.medsci.cn/rand) 80 random sequences, the sequence from small to large, sorting before 40 as intervention group, after 40 in the control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
单盲:通过第三方数据收集者负责患者的基线、干预前和转出ICU后2周的数据收集且数据收集者不清楚患者所在的研究组,避免主观臆想对试验结果的影响。 患者对于自身分在对照组还是干预组并不知情,避免心理效应产生偏倚影响结果。 |
|
Blinding: |
Single blinded: use a third-party data collector to collect data at baseline, before intervention, and 2 weeks after transferring out of the ICU without knowing which study group the patient was in to avoid subjectively influencing the results of the trial. Patients do not know whether they are in the control group or the intervention group, so as to avoid the bias of psychological effects affecting the results. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
non |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |